A groundbreaking three-year Swedish trial reveals that a gentler, slower approach to peanut immunotherapy can transform the lives of allergic toddlers, enabling most to safely tolerate the equivalent ...
Peanut oral immunotherapy safe for young children aged 1 to 3 years with slow up-dosing and low maintenance dosing. HealthDay News — Peanut oral immunotherapy (OIT) using slow up-dosing and low ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results